News

| Technology and Life Sciences
August 3rd, 2017

Gornitzky represents the underwriters, led by Cantor Fitzgerald, in Kamada's follow-on offering. 

Gornitzky represented the underwriters, led by Cantor Fitzgerald, in the USD 15 million follow-on offering of Kamada Ltd. on the NASDAQ Global Select Market. Kamada is a plasma-derived protein therapeutics company focused on orphan indications, and its shares are dually traded on the NASDAQ and the Tel Aviv Stock Exchange.

Cantor Fitzgerald acted as sole book-running manager for the offering. Raymond James, Oppenheimer & Co., Ladenburg Thalmann and Chardan acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Yoav Meer (Associate), Danielle Skald (Associate) and Sharon Strauss (Associate).

February 2nd, 2017

Gornitzky represented the lead investors, Y.T.Y. Lenny Investments Ltd. in a Series A venture capital investment round in Guardian Optical Technologies Ltd

Guardian Optical Technologies is an innovative Israeli startup developing an advanced 3D sensor. Guardian's sensor makes cars safer and enables them to distinguish between still objects and human beings thanks to the presence of a beating heart. This sensor will prevent drivers from forgetting infants in the car as well as serve as a sensor for seat belts, the airbag system, monitoring driving, movement recognition, driver recognition, black boxes and many other applications.

 

Y.T.Y. Lenny Investments Ltd. was represented by Timor Belan (Partner) and Avi Meer.

August 17th, 2016

Gornitzky represents the American car manufacturing Ford in in a multi-million dollar acquisition of SAIPS, an Israeli computer vision and machine learning company. 

Gornitzky represented the American car manufacturing Ford in connection with the acquisition of SAIPS, an Israeli computer vision and machine learning company. Ford announced the acquisition as part of its pledge to develop a commercial fully autonomous vehicle fleet by 2021.

 

See full story in Globes

 

Ford was represented by Chaim Friedland (Partner) Daniel Paserman (Partner, Tax), Yehonatan Raff, Aviad Rabinowitz, Danielle Skald (Tax) and Bar Sarafian.

April 12th, 2016

Gornitzky represented Y.T.Y. Lenny Investments Ltd in a venture capital investment in Guardian Optical Technologies Ltd which is developing an 3D sensor for vehicles  

Gornitzky represented Y.T.Y Lenny Investments Ltd. in a venture capital investment in Guardian Optical Technologies Ltd. Guardian Optical Technologies is an innovative Israeli startup developing an advanced 3D sensor that makes cars safer and enables them to distinguish between still objects and human beings thanks to the presence of a beating heart. This sensor will prevent drivers from forgetting infants in the car as well as serve as a sensor for seat belts, the airbag system, monitoring driving, movement recognition, driver recognition, black boxes and many other applications. This 3D sensor is expected to prevent car accidents and save lives.

 

Y.T.Y Lenny Investments Ltd. and its affiliates were represented by Timor Belan (Partner) and Avi Meer.

 

November 11th, 2015

Gornitzky represented the underwriters, led by Piper Jaffray, in Vascular Biogenics Ltd.’s (operating as VBL Therapeutics) USD 15 million offering of shares and warrants on the NASDAQ Global Market. VBL Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.

Gornitzky represented the underwriters, led by Piper Jaffray, in Vascular Biogenics Ltd.’s (operating as VBL Therapeutics) USD 15 million offering of shares and warrants on the NASDAQ Global Market. VBL Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.

 

Piper Jaffray & Co. acted as sole bookrunner for the offering. JMP Securities acted as lead manager and Roth Capital Partners and LifeSci Capital acted as co-managers.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

 

July 22nd, 2015

Gornitzky represents the underwriters, led by Nomura and Roth Capital, in RedHill Biopharma’s USD 40 million public offering of ADSs

 

 

 

 

 

Gornitzky represented the underwriters, led by Nomura and Roth Capital Partners, in RedHill Biopharma’s USD 40 million public offering of American Depository Shares (ADSs) on the NASDAQ Capital Market. RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on drugs for inflammatory and gastrointestinal diseases, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).

 

Nomura Securities and Roth Capital Partners acted as joint book-running managers for the offering. MLV & Co. and H.C. Wainwright acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Sagit Amit Evan.

 

 

March 25th, 2015

Gornitzky & Co. represented the underwriters, led by Wells Fargo and RBC, in the USD 40 million initial public offering of SteadyMed Ltd. on the NASDAQ Global Market. 

Gornitzky & Co. represented the underwriters, led by Wells Fargo and RBC, in the USD 40 million initial public offering of SteadyMed Ltd. on the NASDAQ Global Market. SteadyMed is a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parenteral delivery needs.

Wells Fargo Securities and RBC Capital Markets acted as joint book-running managers for the offering. JMP Securities acted as lead manager for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

February 9th, 2015

Gornitzky represented 3D Systems Corporation (NYSE: DDD) in its USD 97 million acquisition of all outstanding shares in Cimatron Ltd. (NASDAQ: CIMT), a leading provider of integrated 3D CAD/CAM software products.

Gornitzky represented 3D Systems Corporation (NYSE: DDD) in its USD 97 million acquisition of all outstanding shares in Cimatron Ltd. (NASDAQ: CIMT), a leading provider of integrated 3D CAD/CAM software products.

 

3D Systems Corporation, a market leader in 3D printing, was represented by Chaim Friedland (Partner), Assaf Harel, Yehontan Raff, Danielle Skald (Tax), Bar Sarafian (Labor Law) and Ben Goldman.

January 15th, 2015

Gornitzky represented Le Peigne in its investment in Moovit, as part of a consortium of investors in Moovit’s USD 50 million financing round. 

Gornitzky represented Le Peigne in its investment in Moovit, as part of a consortium of investors in Moovit’s USD 50 million financing round. Le Peigne is controlled by the Arnault Group, which also controls Christian Dior and LVMH Moet-Hennessy—Louis Vitton. 

 

Moovit is a mobile application that enables users to track information on public transport. 

 

Le Peigne was represented by Chaim Friedland (Partner) and Yoav Meer.

December 29th, 2014

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliate, Fortune China Ltd. in a USD 10 million investment in Highcon Systems Ltd.

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership and its affiliate, Fortune China Ltd., in a USD 10 million investment in Highcon Systems Ltd. 

 

Highcon Systems Ltd. is the manufacturer of a revolutionary digital converting solution for the Direct-to-Pack Folding Carton sector, the Highcon Euclid - the world’s first production digital cutting and creasing machine.

 

Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Ltd. were represented by Timor Belan (Partner) and Avi Meer.

November 19th, 2014

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 45 million initial public offering of NeuroDerm Ltd. on the NASDAQ Global Market.

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 45 million initial public offering of NeuroDerm Ltd. on the NASDAQ Global Market.


Jefferies and Cowen and Company acted as joint book-running managers for the offering. Oppenheimer & Co. and Roth Capital Partners acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yehonatan Raff.

October 6th, 2014

Gornitzky represented the underwriters, led by Deutsche Bank, in the USD 40 million initial public offering of Vascular Biogenics Ltd. (operating as VBL Therapeutics) on the NASDAQ Global Market.

Gornitzky represented the underwriters, led by Deutsche Bank, in the USD 40 million initial public offering of Vascular Biogenics Ltd. (operating as VBL Therapeutics) on the NASDAQ Global Market.

 

Deutsche Bank acted as book-running manager for the offering. JMP Securities and Oppenheimer & Co. acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

August 31st, 2014

Gornitzky represented 3D Systems Inc. in the USD 120 million cash acquisition of Simbionix.

Gornitzky represented 3D Systems Inc. in the USD 120 million cash acquisition of Simbionix USA Corp., a developer of 3D virtual reality simulation systems for training doctors to conduct complex surgical and treatment procedures.

 

3D Systems Inc. (NYSE: DDD) was represented by Chaim Friedland (Partner), Daniel Paserman (Partner, Tax), Avi Meer and Danielle Skald.

April 2nd, 2014

Gornitzky represented Altria Group Inc. in its acquisition of Green Smoke Inc., an electronic cigarette business, for USD 110 million and up to USD 20 million in incentive payments.

Gornitzky represented Altria Group Inc. (NYSE: MO) in its acquisition of Green Smoke Inc., an electronic cigarette business, and its affiliates. Altria, which owns the top U.S. cigarette maker, Philip Morris USA, has purchased Green Smoke for USD 110 million and up to USD 20 million in incentive payments.

 

Altria Group Inc. was represented by Chaim Friedland (Partner, Corporate M&A), Yoram Arad (Partner, High-Tech), Ari Fried (Partner, Corporate M&A), Idan Baki (Partner, Finance), Michael Ayalon (Partner, Labor), Dafna Michalevich-Bacharach (High-Tech), Avi Meer (Corporate) and Joanna Yanowsky (Labor).

March 5th, 2014

Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 151 million secondary public offering of shares of Enzymotec Ltd. on the NASDAQ Global Select Market.


Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 151 million secondary public offering of shares of Enzymotec Ltd. on the NASDAQ Global Select Market.

 

Bank of America Merrill Lynch and Jefferies acted as joint book-running managers for the offering. Wells Fargo Securities acted as lead manager for the offering and Canaccord Genuity and Wedbush Securities acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

August 6th, 2013

Gornitzky represented TRAX Technology Solutions Pte Ltd. in finalizing a USD 6.6 million A-round financing agreement with one of Singapore's largest private equity funds.

Gornitzky represented TRAX Technology Solutions Pte Ltd. in finalizing a USD 6.6 million A-round financing agreement with one of Singapore's largest private equity funds. The terms of the agreement include the immediate cash infusion of USD 6.6 million, with an option for an additional USD 14 million (approximately) available over the next 18 months.

 

TRAX Technology Solutions Pte Ltd. is a leading provider of in-store auditing and shelf monitoring solutions for the fast moving consumer goods industry (FMCG).

 

TRAX was represented by Chaim Friedland (Partner), Yoram Arad (Partner) and Yehonatan Raff.

 

June 10th, 2013

Gornitzky represented Kadimastem Ltd. in its USD 5.5 million initial public offering on the Tel Aviv Stock Exchange.

Gornitzky represented Kadimastem Ltd. (TASE: KDST) in its initial public offering of 3.1 million shares on the Tel Aviv Stock Exchange, for approximately USD 5.5 million. The underwriter of the offering was Rosario Capital Ltd.


Kadimastem is an Israeli biotechnology company focused on the industrial development and commercialization of human pluripotent stem cell-based products for the pharmaceutical and/or medical treatment of diabetes, neurodegenerative diseases and other indications.


Kadimastem Ltd. was represented by Sharon Werker-Sagy (Partner) and Etai Mashiah.

June 9th, 2013

Gornitzky represented Rutledge Vine Capital in its second equity investment in Getonic Ltd., a private company which developed a social-shop platform. 

Gornitzky represented Rutledge Vine Capital in its second equity investment in Getonic Ltd., a private company which developed a social-shop platform. Rutledge's investment in Getonic is its second investment in the company following an investment made in mid-2012, where it was also represented by Gornitzky.

 

Rutledge Vine Capital is a global Super Angel Investor that provides early stage venture funding to startup and seed companies and technovation research projects across the world.

 

Rutledge was represented by Ari Fried (Partner).

June 4th, 2013

Gornitzky & Co. represented Starhome BV in their purchase of MACH, which is being divested by Syniverse Technologies LLC.

Gornitzky & Co. represented Starhome BV in their purchase of MACH’s data clearing and NRTRDE business within the European Economic Area, under a corporate divestiture by Syniverse Technologies LLC, as mandated and instructed by the European Commission (antitrust). The acquisition is contingent upon approval of the transaction by the European Commission and other applicable jurisdictions.

 

Starhome is a leading global provider of international roaming solutions and their products are used by more than 200 mobile operators worldwide, including by 20 of the 30 largest operators in the world. MACH is a leading provider of cloud-based managed communication services worldwide.

 

Starhome BV was represented by Chaim Friedland (Partner, Corporate/M&A), Yoram Arad (Partner, Technology/Commercial), Yisrael Spero (Partner, Corporate/M&A/Regulatory), Yehonatan Raff, Avi Meer and Ariel Davis.

February 14th, 2013

Gornitzky represented Rutledge Vine Capital in its equity investment in Tok Media International Ltd., a private company in the social media space.

Gornitzky represented Rutledge Vine Capital in its equity investment in Tok Media International Ltd., a private company in the social media space. Rutledge's investment in Tok Media marks its fourth investment in Israel represented by Gornitzky.


Rutledge Vine Capital is a global Super Angel Investor that provides early stage venture funding to startup & seed companies and technovation research projects across the world.


Rutledge was represented by Mr. Ari Fried (Partner) and Mr. Yoav Meer.

December 10th, 2012

Gornitzky & Co. represented a group of investors in their investment in iMingle Ltd., an online Facebook application.

Gornitzky & Co. represented a group of investors in their investment in iMingle Ltd., an online Facebook application.

 

iMingle is the leading online live party and events application on Facebook, with over 6.5 million registered users.

 

The investors were represented by Chaim Friedland (Partner) and Yehonatan Raff.

 

October 19th, 2012

Gornitzky & Co. represented Fortissimo Capital in their USD 80.3 million purchase of Starhome BV, a subsidiary of Comverse Technology Inc. (NASDAQ: CMVT), as well as in the financing of the transaction.

Gornitzky & Co. represented Fortissimo Capital,  in their USD 80.3 million purchase of Starhome BV, a subsidiary of Comverse Technology Inc. (NASDAQ: CMVT), as well as in the financing of the transaction.

 

In addition to legal representation of the private equity fund in the purchase and financing of the transaction, Gornitzky & Co. also negotiated a complex transitional services agreement, which provides Starhome with continued support services from Comverse.

 

Starhome is a leading provider of international roaming solutions and their products are used by more than 200 mobile operators worldwide, including by 20 of the 30 largest operators in the world. Fortissimo Capital is a group of private equity funds managing half a billion dollars.

 

Fortissimo was represented by Chaim Friedland (Partner, Corporate/M&A), Benjamin Waltuch (Partner, Corporate/M&A), Yoram Arad (Partner, Technology/Commercial), Idan Baki (Partner, Banking/Finance), Avner Finkelshtein (Antitrust), Yehonatan Raff  and Ariel Davis.

December 21st, 2011

Gornitzky represented Cabaret Security Ltd. and Arba One Inc., two of the main selling shareholders in the $40 million financing of Cyber-Ark Software Ltd.

Gornitzky represented Cabaret Security Ltd. and Arba One Inc., two of the main selling shareholders in the $40 million financing of Cyber-Ark Software Ltd.

 

The transaction involved a USD 40 million joint investment in Cyber-Ark by JVP (one of Israel's prominent VC funds) and Goldman Sachs, in a combination of a primary (issuance) and secondary (purchase from existing shareholders) stock transaction.

 

As of the closing of the financing round, Cyber-Ark's shareholders are JVP, Vertex Venture Capital, Goldman Sachs, JPMorgan Chase Partners, Cabaret Security Ltd. and Arba One Inc., Softbank Ltd. affiliate Seed Capital Partners, and Nochi Dankner-controlled IDB Development Corp. Ltd.

 

The team handling the representation included Chaim Friedland (Partner), Avner Finkelshtein and Yisrael Spero.

July 30th, 2017

Gornitzky represents Priority in its acquisition of Monitin Information Systems' ERP operations.

Gornitzky represented Priority Software in its acquisition of the entire ERP operations of Monitin Information Systems, a long-standing ERP developer and implementor for numerous Israeli corporations.

 

Priority is a portfolio company of Fortissimo Capital, a prominent Israeli private equity fund and this is its third acquisition in recent months represented by our firm.

 

We congratulate Priority on its continued expansion in Israel and abroad.

 

Priority was represented by Sagit Amit Evan (Senior Associate), Eitan Mor (Associate), Daniel Reshef (Associate) and Ori Sheinkman (Associate).

January 17th, 2017

Gornitzky & Co. Upgrades its Technology and Hi-Tech Practice through the addition of two new partners, proven leaders in the Technology, Hi-Tech and VC fields.

Gornitzky & Co. carried out a major move through the addition of two new partners, proven leaders in the Technology, Hi-Tech and VC fields.

 

Daniel Marcus and Shlomo Landress, previously with the Tel Aviv law firm of Amit, Pollak, Matalon & Co., will head up Gornitzky & Co.'s Technology practice and expand the capacity of the firm's International team.

 

Gornitzky & Co. is one of Israel's leading law firms, with its clients consisting of some of the central players in the Israeli economy and business community. The addition of these two partners comes as part of the Firm's strategy to grow and expand its capabilities in the Technology, Hi-Tech and VC fields, and more broadly, in its cross-border activities.

 

Daniel Marcus was born in the United States and is a graduate of Columbia University in New York City. Mr. Marcus has vast experience in the areas of Hi-Tech investments, Mergers & Acquisitions, strategic collaborations and joint ventures involving major international corporations. He regularly advises founders, VC funds and start-up companies on a broad spectrum of matters, and is an expert in the areas of agreements relating to R&D, licensing, distribution, and other related commercial arrangements.

 

Shlomo Landress, who holds an LLM from NYU, focuses his practice on U.S. securities matters, and regularly advises clients on private placements, public offerings, and public reporting and filings of companies listed on the NASDAQ. Mr. Landress also advises clients in Mergers & Acquisitions, as well as representing investors and companies in early stage and VC investment transactions. Mr. Landress was formerly the general counsel to the Israel Economic Mission to North America and was an associate in the Corporate Department in the New York office of Arnold & Porter LLP.

Gornitzky & Co. is delighted to welcome these two gentlemen to its team.

 

Pinhas Rubin, the Chairman of the Firm stated: "For several years now Gornitzky & Co. has been at the forefront of the various fields of the corporate and commercial law practice, with cutting edge professional capabilities in areas such as Litigation, Tax, M&A, Capital Markets, Finance, Telecommunications, Real Estate and Energy. The Firm's clients include many of Israel's leading corporations as well as major global corporations in the activities in Israel. It is only natural that the Firm would seek to expand its capabilities in the areas of the law relevant to the international business community, and specifically, in the Technology and Hi-Tech space which is one of Israel's central growth drivers. I have no doubt that the addition of these two new partners to our Firm, will contribute to the Firm's continued growth, expansion of its client base and its position as a top rated law firm and provider of first rate legal advice in each of the legal disciplines and services in which it provides services to its clients."

 

Chaim Friedland, who heads the Firm's international practice, added: "The addition of these two partners, whose work I've admired for many years, is a major boost to our activity in the international space, which already spans several continents and a variety of disciplines, including energy, consumer products and technology. On a personal level, I am delighted that we are adding two professionals with excellent reputations in the market, both professional and personal, and I am certain that the will find a warm and welcoming home in Gornitzky, in general, in in the International Practice Group, in particular."

 

Messrs. Marcus and Landress added: "We are excited to join Gornitzky & Co. and we are certain that this superb platform will allow us to provide a broad menu of excellent services to a diverse client base, both Israeli as well as international. We are deeply grateful to our former partners and colleagues at Amit, Pollak, Matalon & Co., and we are thankful for the many wonderful years of cooperation; we wish them all the best of luck in the future."

 

Download as PDF

July 6th, 2016

Yoram was quoted in The Times of Israel Article “Israel walks tightrope in clash with Facebook, Google”:

February 16th, 2016

Gornitzky represented the sole investor in a USD 2 million venture investment in a healthcare startup.

Gornitzky represented the sole investor in a USD 2 million venture investment in a healthcare startup.

The investor was represented by Ori Yitzhak (Partner, Corporate/M&A), Gil Grady (Partner, Tax) and Avi Meer.


The investment was the investor’s second investment in the startup following the startup’s USD 3 million Series A round in August 2013. Gornitzky (Yisrael Spero (Partner, Corporate M&A) and Avi Meer) represented the investor in the Series A round.

September 16th, 2015

Gornitzky & Co. represented Fortissimo Capital Fund in its acquisition of Fishman Thermo Technologies LTD. Fishman is a leading manufacturer and supplier of cooling system products for the automotive industry.

Gornitzky & Co. represented Fortissimo Capital Fund in its acquisition of Fishman Thermo Technologies LTD from Tene for Investment F.E., Limited Partnership, Origo 1 Manof Fund, Limited Partnership, Origo 2 Manof Fund, Limited Partnership & Ilanit Cohen. Fishman is a leading manufacturer and supplier of cooling system products for the automotive industry.

Fortissimo Capital Fund was represented by Chaim Friedland (Partner, Corporate/M&A), Avner Finkelshtein (Partner, Antitrust), Yehonatan RafAvi Meer, Nir Knoll and Noa Schweitzer

July 21st, 2015

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in NeuroDerm's USD 77 million follow-on offering on NASDAQ

 

 

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 77 million follow-on offering of NeuroDerm Ltd. on the NASDAQ Global Market. NeuroDerm Ltd., is a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases.


Jefferies and Cowen and Company acted as joint book-running managers for the offering. Raymond James & Associates and Roth Capital Partners acted as co-managers for the offering.

  

The underwriters were represented by Chaim Friedland (Partner) and Ari Fried (Partner).

 

February 15th, 2015

Gornitzky & Co. represented the underwriters, led by Wells Fargo, in RedHill Biopharma’s USD 14.4 million public offering of American Depository Shares (ADSs) on the NASDAQ Capital Market.

Gornitzky & Co. represented the underwriters, led by Wells Fargo, in RedHill Biopharma’s USD 14.4 million public offering of American Depository Shares (ADSs) on the NASDAQ Capital Market. RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on drugs for inflammatory and gastrointestinal diseases, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).

 

Wells Fargo Securities acted as lead book-running manager and Roth Capital Partners acted as joint book-running manager for the offering. MLV & Co acted as co-manager for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Sagit Amit Evan.


For more information on our capital markets practice, please click here.

February 4th, 2015

Gornitzky represented Le Peigne in its investment in Taboola, as part of a consortium of investors in Taboola’s USD 117 million financing round. 

Gornitzky represented Le Peigne in its investment in Taboola, as part of a consortium of investors in Taboola’s USD 117 million financing round. Le Peigne is controlled by the Arnault Group, which also controls Christian Dior and LVMH Moet-Hennessy—Louis Vitton.

Taboola is a leading content discovery and marketing platform, serving over 130 billion recommendations to over 350 million unique visitors every month.

Le Peigne was represented by Chaim Friedland (Partner) and Yoav Meer.

December 29th, 2014

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliate, Fortune China Ltd. in a USD 5 million investment in Vascular Graft Solutions Ltd.

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliate, Fortune China Ltd. in a USD 5 million investment in Vascular Graft Solutions Ltd.

 

Vascular Graft Solutions Ltd. is a developer of innovative solutions to improve the outcome of bypass surgery and patients’ quality of life. 

 

Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Ltd. were represented by Timor Belan (Partner) and Assaf Harel.

November 26th, 2014

Gornitzky represented Northland Capital Markets in the USD 10 million follow-on offering of On Track Innovations Ltd. (NASDAQ: OTIV) on the NASDAQ Global Market.

Gornitzky represented Northland Capital Markets in the USD 10 million follow-on offering of On Track Innovations Ltd. (NASDAQ: OTIV) on the NASDAQ Global Market.  Northland Securities acted as sole underwriter for the offering.

 

Northland Capital Markets, a boutique investment banking firm that focuses on growth companies and institutional investors, was represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

November 9th, 2014

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliate, Fortune China Ltd. in a USD 12 million investment in CNoga Medical Ltd.

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership and its affiliate, Fortune China Ltd., in a USD 12 million investment in CNoga Medical Ltd.

 

Cnoga Medical Ltd. is a developer of home medical screening devices using non-invasive monitoring technology.

 

Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Ltd. were represented by Timor Belan (Partner) and Ariel Davis.

September 15th, 2014

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliate, Fortune China Ltd. in a USD 12.5 million investment in InSightec Ltd.

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership and its affiliate, Fortune China Ltd., in a USD 12.5 million investment in InSightec Ltd.

 

InSightec Ltd. is a global leader and pioneer in MR-guided focused ultrasound therapy for non-invasive treatment of various clinical indications.

 

Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Ltd. were represented by Timor Belan (Partner), Yehonatan Raff and Bat-Chen Mazor.

August 5th, 2014

Gornitzky & Co. represented the underwriters, led by Credit Suisse and Jefferies in Macrocure Ltd.’s USD 53.5 million initial public offering on the NASDAQ Global Market.

Gornitzky & Co. represented the underwriters, led by Credit Suisse and Jefferies in Macrocure Ltd.’s USD 53.5 million initial public offering on the NASDAQ Global Market.

Credit Suisse and Jefferies acted as joint book-running managers for the offering. Nomura Securities and Oppenheimer & Co. acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

March 26th, 2014

Gornitzky & Co. represented the underwriters, led by Credit Suisse, Jefferies and BMO Capital Markets, in MediWound Ltd.’s USD 80.5 million initial public offering on the NASDAQ Global Market.


Gornitzky & Co. represented the underwriters, led by Credit Suisse, Jefferies and BMO Capital Markets, in MediWound Ltd.’s USD 80.5 million initial public offering on the NASDAQ Global Market.

 

Credit Suisse, Jefferies and BMO Capital Markets acted as joint book-running managers for the offering. Oppenheimer & Co. acted as co-manager for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

October 3rd, 2013

Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 71 million initial public offering of Enzymotec Ltd. on the NASDAQ Global Select Market.

Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 71 million initial public offering of Enzymotec Ltd. on the NASDAQ Global Select Market.

 

Bank of America Merrill Lynch and Jefferies LLC acted as joint book-running managers for the offering. Wells Fargo Securities, LLC acted as lead manager for the offering and Canaccord Genuity and Wedbush Securities acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

July 19th, 2013

Gornitzky represented YES Pharma Ltd. in its purchase of 33% ownership of Stereokem Inc., a developer and manufacturer of active pharmaceutical ingredients (APIs).

Gornitzky represented YES Pharma Ltd. in its purchase of 33% ownership of Stereokem Inc. a developer and manufacturer of active pharmaceutical ingredients (APIs). Stereokem is a US-based pharmaceutical industry leader, with much of its business concentrated in India.

 

Yes Pharma Ltd. is a distribution company, involved in both exclusive representation and global supply of pharmaceutical ingredients, with specialization in providing full sourcing options, complete technical capabilities and regulatory support for a wide range of APIs.

 

Yes Pharma was represented by Yisrael Spero (Partner) and Ariel Davis.

June 9th, 2013

Gornitzky represented Rutledge Vine Capital in its second equity investment in Getonic Ltd., a private company which developed a social-shop platform. 

Gornitzky represented Rutledge Vine Capital in its second equity investment in Getonic Ltd., a private company which developed a social-shop platform. Rutledge's investment in Getonic is its second investment in the company following an investment made in mid-2012, where it was also represented by Gornitzky.

 

Rutledge Vine Capital is a global Super Angel Investor that provides early stage venture funding to startup and seed companies and technovation research projects across the world.

 

Rutledge was represented by Ari Fried (Partner).

June 5th, 2013

Gornitzky & Co. represented the underwriters led by Morgan Stanley and Jefferies in the USD 59 million initial public offering of Kamada Ltd. on NASDAQ.

Gornitzky & Co. represented the underwriters, led by Morgan Stanley and Jefferies, in the USD 59 million initial public offering of Kamada Ltd. on the NASDAQ Global Select Market.

 

Kamada, a biopharmaceutical company engaged in specialty life-saving therapeutics, was traded on the Tel Aviv Stock Exchange prior to the NASDAQ offering and its shares are now traded on both the TASE and NASDAQ.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

April 24th, 2013

Gornitzky advised Prolor Biotech Inc. in their merger with Opko Health Inc., under which Opko will acquire Prolor in a stock-for-stock merger valued at approximately USD 480 million.

Gornitzky advised Prolor Biotech Inc. (AMEX: PBTH; TASE: PBTH) in connection with their proposed merger with Opko Health Inc. (NYSE: OPK). Under the merger agreement, Opko will acquire Prolor for USD 480 million in shares, one third more than its market cap of approximately USD 370 million. The merger is subject to various conditions, including stockholder approval and regulatory approvals.

 

Prolor Biotech Inc., a biopharmaceutical company focused on developing and commercializing longer-acting proprietary versions of already approved therapeutic proteins, was represented by Chaim Friedland (Partner, Corporate), Gil Grady (Partner, Tax), Dubi Gross (Partner, Corporate), Avner Finkelshtein (Antitrust), Yehonatan Raff and Ariel Davis.

February 1st, 2013

Gornitzky & Co. represented one of the world's leading banks in the Israeli aspects of a USD 50 million loan facility to an international biotechnology company with an Israeli subsidiary.

Gornitzky & Co. represented one of the world's leading banks (traded on the Deutsche Börse and the NYSE) in the Israeli aspects of a USD 50 million loan facility to an international biotechnology company with an Israeli subsidiary.

 

The bank was represented by Benjamin Waltuch (Partner), Idan Baki (Partner) and Ariel Davis.

November 29th, 2012

Gornitzky & Co. acted as Israeli counsel to Geni Inc., an online application for researching and building family trees based in California, in connection with its acquisition by its Israel-based rival, MyHeritage Ltd.

Gornitzky & Co. acted as Israeli counsel to Geni Inc., an online application for researching and building family trees based in California, in connection with its acquisition by its Israel-based rival, MyHeritage Ltd.

 

Gornitzky advised Geni in connection with the Israeli facets of the deal, including recommendations regarding the structure of the transaction.

 

Geni was represented by Chaim Friedland (Partner) and Yisrael Spero.

April 30th, 2012

Gornitzky represented Kadimastem Ltd. in their successful negotiations with Merck Serono S.A. for the entry into a long-term collaboration between the companies in drug discovery and screening to discover new drugs for the treatment of Multiple Sclerosis.

Gornitzky represented Kadimastem Ltd. in their successful negotiations with Merck Serono S.A. for the entry into a long-term collaboration between the companies in drug discovery and screening to discover new drugs for the treatment of the neurological disease Multiple Sclerosis. As part of the joint project between the two companies, Kadimastem's innovative and breakthrough platform, using human stem cells-derived functional tissues, will be applied to test potential new drugs for the treatment of the neurological disease.

 

Kadimastem is an Israeli biotechnology company focused on the industrial development and commercialization of human pluripotent stem cell-based products for the pharmaceutical and/or medical treatment of diabetes, neurodegenerative diseases and other indications.

 

Mr. Yoram Arad (Partner) and Mr. Idan Baki (Partner) led the representation.